Alzheimer’s Disease

The experimental Alzheimer’s drug gantenerumab is the “first and only” anti-amyloid antibody being investigated for subcutaneous administration and could potentially be given to patients...

The rate of schizophrenia diagnoses rose significantly for Black nursing home residents with dementia after the CMS National Partnership to Improve Dementia Care launched in 2012, a new analysis finds.

People with early Alzheimer’s who are treated with the drug donepezil maintain mitochondrial function in their muscles when compared to their untreated peers, researchers report.

The outlook for the Alzheimer’s drug aducanumab (Aduhelm) is looking up, investigators say. There are small increases in the number of Aduhelm prescribers, and an uptick in patients for whom the...

Risk for AD increased for parents of individuals with ADHD; associations attenuated with decreasing genetic relatedness

In a smartphone-enabled study, adults aged 70 years and older had better cognitive performance the same day that they reported having more frequent, pleasant social interactions than usual — and on the...

Parents of children diagnosed with attention deficit hyperactivity disorder are more likely to receive a diagnosis of Alzheimer’s than their peers whose children do not have the condition, investigators...

The majority of patients with Alzheimer’s disease would not have been eligible to take part in the clinical trials of the new controversial Alzheimer’s drug  aducanumab (Aduhelm), according...

The FDA is being asked to help explain how Aduhelm (aducanumab) met accelerated approval criteria when so many experts — including internal advisers — have flagged insufficient safety and efficacy...

Treatments targeting inflammation could help reverse or at least slow the accumulation of pathologic tau protein in the brain — benefitting people with early dementia, investigators say.